Volume 19, Issue 1 (Spring 2022)                   Sci J Iran Blood Transfus Organ 2022, 19(1): 10-23 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mohammadi S, Karimian M, Khodakarimi S, babahajiyani S, Pourali A, Vafaei S. Identification and risk assessment in the process of blood donation in a fixed blood collection center of Saqez city by Failure Mode and Effects Analysis. Sci J Iran Blood Transfus Organ 2022; 19 (1) :10-23
URL: http://bloodjournal.ir/article-1-1419-en.html
Full-Text [PDF 581 kb]   (1222 Downloads)     |   Abstract (HTML)  (1803 Views)
Full-Text:   (1945 Views)
   References:
  1. Yarmohammadian MH, Jafarian Jazi M, Khorasani E, Atighechian G. Risk assessment in the intensive care unit; nurse's perspectives. Int J Health Syst Disaster Manag 2014; 2(3): 147-52.
  2. WHO. Laboratory Biosafety Manual. 4th ed. Geneva: WHO; 2020. p. 16-7.
  3. Anes V, Henriques E, Freitas M, Reis L. A new risk prioritization model for failure mode and effects analysis Qual. Reliab Eng In 2018; 34(2): 516-28.
  4. Babaie MA, Zanjani MR. New approach on organizational effectiveness. Risk management. Tadbir J 2005; 6(170): 3-6. [Article in Farsi]
  5. Tariverdi Y, Damghi Golodar Z. Relationship between risk management and corporate performance. Journal of Financial Accounting Audit 2014; 4(14): 43-62.
  6. Jcaho.org [homepage on the Internet]. Chicago: Joint Commission on Accreditation [updated 2009 May 16; cited 2009 Jul 9]. Available from: http://www.cancer-pain.org
  7. WHO. Towards 100% voluntary blood donation:a global framework for action; 2010.
  8. WHO. Blood donor selection: guidelines on assessing donor suitability for blood donation:world health organization; 2012.
  9. Mohammed H, Osman T. Voluntary Blood Donation among Medical Students in a Resource-limited Country. JPHDC  2016; 2(3): 257–67.
  10. WHO. Voluntary unpaid blood donations must increase rapidly to meet 2020 goal. http://www.who.int/campaigns/world-blood-donor-day/2016/event/en/. Accessed 17 Mar 2016.
  11. Nigatu A, Demissie DB. Knowledge, Attitude and Practice on Voluntary Blood Donation and Associated Factors among Ambo University Regular Students, Ambo Town, Ethiopia. JCMHE 2014; 4(5): 1000315.
  12. WHO. The Melbourne Deceleration on 100% Voluntary Non_remunerated Donation of Blood and Blood components. Geneva: WHO; 2009.
  13. WHO. Screening donated blood for transfusion_transmissible infections: recommendation: WHO; 2010.
  14. Reiss RF. Blood donor well-being, a primary responsibility of blood collection agencies. Ann Clin Lab Sci 2011, 41(1): 3-7.
  15. WHO. Annex 2: Quality Risk Management. (Guideline). Geneva, Switzerland: WHO, 2013, 32P. Technical Report Series No 981.
  16. Sedaghat  A,  Ghanjal  A,  Mottaghi   M,    Delavari A, Tavakkoli R. Risk assessment and management of an emergency military field using FMEA method. Military Medicine Journal 2008; 10(3): 167-74. [Article in Farsi]
  17. Chiozza ML, Ponzetti C. FMEA: A model for reducing medical errors. Clinical Chemistry 2009; 404(1): 75-8.
  18. Morelli P, Vinci A, Galetto L, Magon G, Maniaci V, Banfi G. FMECA methodology applied to two pathways in an orthopaedic hospital in Milan. J Prev Med Hyg 2007; 48(2): 54-9.
  19. Van Tilburg CM, Leistikow IP, Rademaker CM, Bierings MB, van Dijk ATH. Health care failure mode and effect analysis: a useful proactive risk analysis in a pediatric oncology ward. Qual Saf Health Care 2006; 15(1): 58-63.
  20. Abbasgholizadeh Rahimi S, Jamshidi A, Ait-Kadi D, Ruiz A. Using Fuzzy Cost-Based FMEA, GRA and Profitability Theory for Minimizing Failures at a Healthcare Diagnosis Service. Qual Reliab Eng Int 2015; 31(4): 601-15.
  21. Trucco P, Cavallin M. A quantitative approach to clinical risk assessment: The CREA method. Saf Sci 2006; 44: 491-513.
  22. Bonfant G, Belfanti P, Paternoster G, Gabrielli D, Gaiter AM, Manes M, et al. Clinical risk analysis with failure mode and effect analysis (FMEA) model in a dialysis unit. JNEPHROL 2010; 23(01): 111-8.
  23. Ookalkar AD, Joshi AG, Ookalkar DS. Quality improvement in haemodialysis process using FMEA Int J Qual Reliab Manag 2009; 26(8): 817-30.
  24. Zeng SX, Tam CM, Tam VWY. Integrating Safety, Environmental and Quality Risks for Project Management Using a FMEA Method. Engineering Economics 2010; 21(1): 44-52.
  25. Basu S. Plant Hazard Analysis and Safety Instrumentation Systems. USA: Academic Press; 1st ed; 2016. p. 8-9.
  26. Arghami S, Kamali K, Radanfar F. Task Performance induced Work Load in Nursing. Johe 2015; 2(3): 45-54. [Article in Farsi]
  27. Javadzadeh Shahshahani H, Yavari M. Side effects of whole blood donation in donors in Yazd. Blood research 2007; 4(2): 87-93.
  28. Kavosi Z, Setoodehzadeh F, Fardid M, Gholami M, Khojastefar M, Hatam M, et al. Risk Assessment of the Processes of Operating Room Department using the Failure Mode and Effects Analysis (FMEA) Method. Jhosp 2017; 16(3): 57-70. [Article in Farsi]
  29. Razaz M, Husein EM, Hassan E. Risk Evaluation in Blood Donation Using Failure Mode and Effective Analysis. Journal of Biomedical Science and Engineering  2021; 14(4): 177-84.
  30. Mohammadi M, Rahi F, Javadi M, Atighechian G, Jabbari A. The Potential Failure Modes and Effects Analysis (FMEA) of the Nursing Care Processes in One of the Sub Specialty Hospitals in Isfahan. Payavard 2017; 11(2): 161-72. [Article in Farsi]
  31. Hoffmann H, Kessler H, Eppel T, Rukavina S, Traue HC. Expression intensity, gender and facial emotion recognition: Women recognize only subtle facial emotions better than men. Acta Psychol 2010; 135(3): 278-83.
  32. Alizadeh, Z. Effect of Vein Finder and Common Venipuncture Method in Anxiety and Psychological Indicators among 3-6-year-old children: A Comparative Study. Navid No 2021; 24(78): 113-24. [Article in Farsi]











Sci J Iran Blood Transfus Organ 2022;19 (1): 10-23
Original Article
 


Identification and risk assessment in the process of blood
donation in a fixed blood collection center of Saqez city
by Failure Mode and Effects Analysis

Mohammadi S.1,2, Karimian M. 1,2, Khodakarimi S. 1,2, Babahajiani S. 1,2,
Poruali A. 1,2, Vafaei S. 1,2



1Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran
2Kurdistan Blood Transfusion Center, Sanandaj, Iran



Abstract
Background and Objectives
Risk is a combination of the likelihood of an incident occurring and the severity of the consequences if that incident were to occur. The aim of this research is to identify and evaluate the risk factors in the blood donation process in a fixed blood collection center of Saqez city by failure mode and effects analysis (FMEA).

Materials and Methods
It is a descriptive-applied study that was performed in a fixed blood collection center of Saqez in 2020. The researcher collected and analyzed the data using FMEA worksheets. Then the risk priority number is obtained by multiplying the three indicators of failure severity (S), the failure probability of occurrence (O), and the failure detection (D). Finally, the priority was based on the failures.

Results
Finally, 30 sub-processes were identified, of which 20 sub-processes with acceptable risk and 10 sub-processes with unacceptable risk were identified. The highest identified risk is related to the donor not paying attention to safety points before and after blood donation with a priority risk number of 168 and the lowest is attributed to the shaker not alarmed when the blood donation process ends with a RPN of 48.

Conclusions 
Many of the failures identified will be reduced or eliminated by training, providing up-to-date equipment, and changing procedures and working methods.

Key words: Risk, Risk Assessment, Blood Donors, Blood Donation




Received:  24 Aug 2021
Accepted: 22 Dec 2021



Correspondence: Khodakarimi S., Master of Health Services Management. Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine and Kurdistan Blood Transfusion Center.
Postal Code: 6681167989, Sanandaj, Iran. Tel: (+9887) 36217302; Fax: (+9887) 36217302
E-mail:
1- Acridine Orange
1- Biological safety cabinet
1- Platelet Concentrate
2- Food and Drug Administration
3- Normal Skin Flora
4- Platelet Rich Plasma-Platelet Concentrate
5- Eosin-Methylene blue
6- Thioglycolate
1- Acridine Orange
1- Biological safety cabinet
1- Platelet Concentrate
2- Food and Drug Administration
3- Normal Skin Flora
4- Platelet Rich Plasma-Platelet Concentrate
5- Eosin-Methylene blue
6- Thioglycolate
sk3005i@yahoo.com

 
Type of Study: Research | Subject: Blood donation
Published: 2022/03/30

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Scientific Journal of Iran Blood Transfus Organ

Designed & Developed by : Yektaweb